Publications by authors named "I Vergote"

Claim this Profile
F
First experience with intraperitoneal Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer.
Yun Wang, Els Van Nieuwenhuysen, Mona-Elisabeth Revheim, Christophe M Deroose, Ane Gerda Zahl Eriksson, Ignace Vergote

Gynecol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors.
Kristoffer Staal Rohrberg, Juanita S Lopez, Mohammed M Milhem, Christian U Blank, Irene Reijers, Ignace Vergote

Cancer Res Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors.
An Coosemans, Jolien Ceusters, Chiara Landolfo, Thaïs Baert, Kainat Jamil, Ignace Vergote

iScience· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined operative and radiotherapeutic treatment for locally recurrent gynaecologic cancer with pelvic wall invasion: A monocentric retrospective study.
Selnur Özkurt, Eva Oldenburger, Vincent Tambeur, Laurence Delombaerde, Thaïs Baert, Ignace Vergote

Brachytherapy· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma.
Dale Garsed, Tibor Zwimpfer, Sian Fereday, Ahwan Pandey, Dinuka Ariyaratne, Ignace Vergote

Res Sq· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis